[XENE] YoY Quarter Result on 30-Jun-2024 [#Q2]

Stock
[XENE] Xenon Pharmaceuticals Inc.
Announcement Date
08-Aug-2024
Financial Year
2024
Quarter
30-Jun-2024 [#Q2]
Profit Trend
QoQ- -20.85%
YoY- -22.05%
Quarter Report
XENE's Result
XENE's Financial Summary
View:
Show?
Quarter Result
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
Revenue 0 0 536 2,218 13,384 0 0 -
PBT -58,257 -47,681 -31,198 -22,326 -214 -10,036 -7,801 39.76%
Tax -333 -220 -40 -217 -39 -29 200 -
NP -57,924 -47,461 -31,158 -22,109 -175 -10,007 -7,801 39.63%
Tax Rate - - - - - - - -
Total Cost 57,924 47,461 31,694 24,327 13,559 10,007 7,801 39.63%
Ratio Analysis
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
NP Margin 0.00 0.00 -5,813.06 -996.80 -1.31 0.00 0.00 -
Per Share
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
EPS -0.75 -0.72 -0.55 -0.53 -0.01 -0.39 -0.55 5.30%
EPS Diluted -0.75 -0.72 -0.55 -0.53 -0.01 -0.39 -0.55 5.30%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.